Supplementary Figure S3 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial

<p>Supplementary Figure 3. Forest plot with subgroup analysis for OS in substudy 1.</p>

Gorde:

Xehetasun bibliografikoak
Egile nagusia:	Fabrice Barlesi (15045504) (author)
Beste egile batzuk:	Pascale Tomasini (4354063) (author), Maryam Karimi (7168769) (author), Stefan Michiels (108030) (author), Judith Raimbourg (15033410) (author), Catherine Daniel (7119086) (author), Henri Janicot (15019596) (author), Anne Madroszyk (15033398) (author), Clarisse Audigier-Valette (15045507) (author), Elisabeth Quoix (321740) (author), Julien Mazieres (15013412) (author), Denis Moro-Sibilot (15033407) (author), Eric Dansin (5576408) (author), Olivier Molinier (15019590) (author), Hugues Morel (15033419) (author), Eric Pichon (15033425) (author), Alexis Cortot (15045510) (author), Josiane Otto (6553544) (author), François Chomy (635983) (author), Pierre-Jean Souquet (3629372) (author), Nicolas Cloarec (15045513) (author), Etienne Giroux-Leprieur (385865) (author), Ivan Bieche (15045516) (author), Ludovic Lacroix (15030059) (author), Sandrine Boyault (9337805) (author), Valery Attignon (15045519) (author), Isabelle Soubeyran (515223) (author), Alain Morel (11665966) (author), Alicia Tran-Dien (14210462) (author), Alexandra Jacquet (14952799) (author), Filippo Gustavo Dall'Olio (15045522) (author), Marta Jimenez (14952288) (author), Jean-Charles Soria (15045525) (author), Benjamin Besse (3497516) (author)
Argitaratua:	2025
Gaiak:	Cancer Therapeutic Research and Development Immuno-oncology Clinical Research and Trials Clinical Trial Results Phase II clinical trials Drug Targets Immunotherapy Checkpoint blockade Lung Cancer Precision Medicine
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

_version_	1849927634656428032
author	Fabrice Barlesi (15045504)
author2	Pascale Tomasini (4354063) Maryam Karimi (7168769) Stefan Michiels (108030) Judith Raimbourg (15033410) Catherine Daniel (7119086) Henri Janicot (15019596) Anne Madroszyk (15033398) Clarisse Audigier-Valette (15045507) Elisabeth Quoix (321740) Julien Mazieres (15013412) Denis Moro-Sibilot (15033407) Eric Dansin (5576408) Olivier Molinier (15019590) Hugues Morel (15033419) Eric Pichon (15033425) Alexis Cortot (15045510) Josiane Otto (6553544) François Chomy (635983) Pierre-Jean Souquet (3629372) Nicolas Cloarec (15045513) Etienne Giroux-Leprieur (385865) Ivan Bieche (15045516) Ludovic Lacroix (15030059) Sandrine Boyault (9337805) Valery Attignon (15045519) Isabelle Soubeyran (515223) Alain Morel (11665966) Alicia Tran-Dien (14210462) Alexandra Jacquet (14952799) Filippo Gustavo Dall'Olio (15045522) Marta Jimenez (14952288) Jean-Charles Soria (15045525) Benjamin Besse (3497516)
author2_role	author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author
author_facet	Fabrice Barlesi (15045504) Pascale Tomasini (4354063) Maryam Karimi (7168769) Stefan Michiels (108030) Judith Raimbourg (15033410) Catherine Daniel (7119086) Henri Janicot (15019596) Anne Madroszyk (15033398) Clarisse Audigier-Valette (15045507) Elisabeth Quoix (321740) Julien Mazieres (15013412) Denis Moro-Sibilot (15033407) Eric Dansin (5576408) Olivier Molinier (15019590) Hugues Morel (15033419) Eric Pichon (15033425) Alexis Cortot (15045510) Josiane Otto (6553544) François Chomy (635983) Pierre-Jean Souquet (3629372) Nicolas Cloarec (15045513) Etienne Giroux-Leprieur (385865) Ivan Bieche (15045516) Ludovic Lacroix (15030059) Sandrine Boyault (9337805) Valery Attignon (15045519) Isabelle Soubeyran (515223) Alain Morel (11665966) Alicia Tran-Dien (14210462) Alexandra Jacquet (14952799) Filippo Gustavo Dall'Olio (15045522) Marta Jimenez (14952288) Jean-Charles Soria (15045525) Benjamin Besse (3497516)
author_role	author
dc.creator.none.fl_str_mv	Fabrice Barlesi (15045504) Pascale Tomasini (4354063) Maryam Karimi (7168769) Stefan Michiels (108030) Judith Raimbourg (15033410) Catherine Daniel (7119086) Henri Janicot (15019596) Anne Madroszyk (15033398) Clarisse Audigier-Valette (15045507) Elisabeth Quoix (321740) Julien Mazieres (15013412) Denis Moro-Sibilot (15033407) Eric Dansin (5576408) Olivier Molinier (15019590) Hugues Morel (15033419) Eric Pichon (15033425) Alexis Cortot (15045510) Josiane Otto (6553544) François Chomy (635983) Pierre-Jean Souquet (3629372) Nicolas Cloarec (15045513) Etienne Giroux-Leprieur (385865) Ivan Bieche (15045516) Ludovic Lacroix (15030059) Sandrine Boyault (9337805) Valery Attignon (15045519) Isabelle Soubeyran (515223) Alain Morel (11665966) Alicia Tran-Dien (14210462) Alexandra Jacquet (14952799) Filippo Gustavo Dall'Olio (15045522) Marta Jimenez (14952288) Jean-Charles Soria (15045525) Benjamin Besse (3497516)
dc.date.none.fl_str_mv	2025-11-25T12:23:17Z
dc.identifier.none.fl_str_mv	10.1158/1078-0432.30705559
dc.relation.none.fl_str_mv	https://figshare.com/articles/figure/Supplementary_Figure_S3_from_Comprehensive_Genome_Profiling_in_Patients_With_Metastatic_Non_Small_Cell_Lung_Cancer_The_Precision_Medicine_Phase_II_Randomized_SAFIR02-Lung_IFCT_1301_Trial/30705559
dc.rights.none.fl_str_mv	CC BY info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Cancer Therapeutic Research and Development Immuno-oncology Clinical Research and Trials Clinical Trial Results Phase II clinical trials Drug Targets Immunotherapy Checkpoint blockade Lung Cancer Precision Medicine
dc.title.none.fl_str_mv	Supplementary Figure S3 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
dc.type.none.fl_str_mv	Image Figure info:eu-repo/semantics/publishedVersion image
description	<p>Supplementary Figure 3. Forest plot with subgroup analysis for OS in substudy 1.</p>
eu_rights_str_mv	openAccess
id	Manara_0c8fe894d421d4aa0fa717b2e021aac3
identifier_str_mv	10.1158/1078-0432.30705559
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/30705559
publishDate	2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY
spelling	Supplementary Figure S3 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 TrialFabrice Barlesi (15045504)Pascale Tomasini (4354063)Maryam Karimi (7168769)Stefan Michiels (108030)Judith Raimbourg (15033410)Catherine Daniel (7119086)Henri Janicot (15019596)Anne Madroszyk (15033398)Clarisse Audigier-Valette (15045507)Elisabeth Quoix (321740)Julien Mazieres (15013412)Denis Moro-Sibilot (15033407)Eric Dansin (5576408)Olivier Molinier (15019590)Hugues Morel (15033419)Eric Pichon (15033425)Alexis Cortot (15045510)Josiane Otto (6553544)François Chomy (635983)Pierre-Jean Souquet (3629372)Nicolas Cloarec (15045513)Etienne Giroux-Leprieur (385865)Ivan Bieche (15045516)Ludovic Lacroix (15030059)Sandrine Boyault (9337805)Valery Attignon (15045519)Isabelle Soubeyran (515223)Alain Morel (11665966)Alicia Tran-Dien (14210462)Alexandra Jacquet (14952799)Filippo Gustavo Dall'Olio (15045522)Marta Jimenez (14952288)Jean-Charles Soria (15045525)Benjamin Besse (3497516)CancerTherapeutic Research and DevelopmentImmuno-oncologyClinical Research and TrialsClinical Trial ResultsPhase II clinical trialsDrug TargetsImmunotherapyCheckpoint blockadeLung CancerPrecision Medicine<p>Supplementary Figure 3. Forest plot with subgroup analysis for OS in substudy 1.</p>2025-11-25T12:23:17ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30705559https://figshare.com/articles/figure/Supplementary_Figure_S3_from_Comprehensive_Genome_Profiling_in_Patients_With_Metastatic_Non_Small_Cell_Lung_Cancer_The_Precision_Medicine_Phase_II_Randomized_SAFIR02-Lung_IFCT_1301_Trial/30705559CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307055592025-11-25T12:23:17Z
spellingShingle	Supplementary Figure S3 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial Fabrice Barlesi (15045504) Cancer Therapeutic Research and Development Immuno-oncology Clinical Research and Trials Clinical Trial Results Phase II clinical trials Drug Targets Immunotherapy Checkpoint blockade Lung Cancer Precision Medicine
status_str	publishedVersion
title	Supplementary Figure S3 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
title_full	Supplementary Figure S3 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
title_fullStr	Supplementary Figure S3 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
title_full_unstemmed	Supplementary Figure S3 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
title_short	Supplementary Figure S3 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
title_sort	Supplementary Figure S3 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial
topic	Cancer Therapeutic Research and Development Immuno-oncology Clinical Research and Trials Clinical Trial Results Phase II clinical trials Drug Targets Immunotherapy Checkpoint blockade Lung Cancer Precision Medicine

Supplementary Figure S3 from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial

Antzeko izenburuak